MA18628A1 - Procede d'obtention de nouvelles compositions pharmaceutiques a base d'aryltrigluoroethanol - Google Patents

Procede d'obtention de nouvelles compositions pharmaceutiques a base d'aryltrigluoroethanol

Info

Publication number
MA18628A1
MA18628A1 MA18829A MA18829A MA18628A1 MA 18628 A1 MA18628 A1 MA 18628A1 MA 18829 A MA18829 A MA 18829A MA 18829 A MA18829 A MA 18829A MA 18628 A1 MA18628 A1 MA 18628A1
Authority
MA
Morocco
Prior art keywords
armyltrigluoroethanol
pharmaceutical compositions
obtaining new
based pharmaceutical
obtaining
Prior art date
Application number
MA18829A
Other languages
English (en)
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of MA18628A1 publication Critical patent/MA18628A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
MA18829A 1978-11-03 1979-10-29 Procede d'obtention de nouvelles compositions pharmaceutiques a base d'aryltrigluoroethanol MA18628A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
MA18628A1 true MA18628A1 (fr) 1980-07-01

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
MA18830A MA18629A1 (fr) 1978-11-03 1979-10-29 Procede d'obtention de nouveaux aryltrifluoroethanols
MA18829A MA18628A1 (fr) 1978-11-03 1979-10-29 Procede d'obtention de nouvelles compositions pharmaceutiques a base d'aryltrigluoroethanol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA18830A MA18629A1 (fr) 1978-11-03 1979-10-29 Procede d'obtention de nouveaux aryltrifluoroethanols

Country Status (27)

Country Link
US (2) US4285943A (fr)
JP (2) JPS5566510A (fr)
AR (2) AR223989A1 (fr)
AT (1) AT368483B (fr)
AU (1) AU527630B2 (fr)
BE (2) BE879786A (fr)
CA (2) CA1142087A (fr)
CH (2) CH647225A5 (fr)
DD (2) DD147048A5 (fr)
DE (2) DE2944293A1 (fr)
DK (2) DK461679A (fr)
EG (1) EG14114A (fr)
ES (1) ES485656A0 (fr)
FI (2) FI793444A (fr)
FR (1) FR2440353A1 (fr)
GB (2) GB2038802B (fr)
GR (2) GR68015B (fr)
IL (2) IL58621A0 (fr)
IT (2) IT7950715A0 (fr)
MA (2) MA18629A1 (fr)
NL (2) NL7908101A (fr)
NZ (2) NZ192020A (fr)
OA (2) OA06373A (fr)
PT (2) PT70407A (fr)
SE (2) SE7909105L (fr)
SU (1) SU925247A3 (fr)
ZA (2) ZA795870B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
JP5715070B2 (ja) 2009-02-16 2015-05-07 ノグラ ファーマ リミテッド アルキルアミド化合物およびその使用
CN104254327A (zh) 2012-02-09 2014-12-31 诺格拉制药有限公司 治疗纤维化的方法
WO2013156413A1 (fr) 2012-04-18 2013-10-24 Nogra Pharma Limited Méthodes de traitement de l'intolérance au lactose
CN113825739A (zh) 2019-02-08 2021-12-21 诺格拉制药有限公司 制备3-(4’-氨基苯基)-2-甲氧基丙酸及其类似物和中间体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
DE2843776A1 (de) * 1977-10-07 1979-04-12 Science Union & Cie (arylalkyl)-alkansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
AT368483B (de) 1982-10-11
GB2034587B (en) 1983-02-09
NL7908101A (nl) 1980-05-07
DE2944294A1 (de) 1980-05-08
AR223989A1 (es) 1981-10-15
ATA701679A (de) 1982-02-15
JPS5566510A (en) 1980-05-20
IL58621A0 (en) 1980-02-29
FI793444A (fi) 1980-05-04
GR68015B (fr) 1981-10-27
NZ192021A (en) 1982-09-07
CH647225A5 (fr) 1985-01-15
PT70407A (en) 1979-12-01
ES8101538A1 (es) 1980-12-16
IT7950715A0 (it) 1979-10-31
DK461679A (da) 1980-05-04
DD151445A5 (de) 1981-10-21
AU527630B2 (en) 1983-03-17
CA1139763A (fr) 1983-01-18
CA1142087A (fr) 1983-03-01
BE879786A (fr) 1980-04-30
OA06372A (fr) 1981-08-31
PT70408A (fr) 1979-12-01
CH641043A5 (fr) 1984-02-15
ZA795870B (en) 1980-10-29
GR69726B (fr) 1982-07-09
FR2440353A1 (fr) 1980-05-30
OA06373A (fr) 1981-08-31
DE2944293A1 (de) 1980-05-08
NZ192020A (en) 1982-12-21
IL58620A0 (en) 1980-02-29
MA18629A1 (fr) 1980-07-01
ES485656A0 (es) 1980-12-16
AR223990A1 (es) 1981-10-15
SU925247A3 (ru) 1982-04-30
US4285943A (en) 1981-08-25
IT7950714A0 (it) 1979-10-31
US4404215A (en) 1983-09-13
GB2034587A (en) 1980-06-11
ZA795871B (en) 1980-10-29
GB2038802A (en) 1980-07-30
JPS5566548A (en) 1980-05-20
AU5241679A (en) 1980-05-08
DD147048A5 (de) 1981-03-18
DK461579A (da) 1980-05-04
BE879787A (fr) 1980-04-30
IL58620A (en) 1982-12-31
GB2038802B (en) 1982-12-08
EG14114A (en) 1983-03-31
SE7909105L (sv) 1980-05-04
NL7908099A (nl) 1980-05-07
FI793445A (fi) 1980-05-04
SE7909106L (sv) 1980-05-04

Similar Documents

Publication Publication Date Title
BE880378A (fr) Procede d'abouchement anastomique
FR2349602A1 (fr) Procede perfectionne d'obtention de 7-ceto-5-steroides
RO73514A (fr) Procede pour l'obtention d'alkylamides
FI790922A (fi) 2,6-dialkoxibenzamider mellanprodukter farmaceutiska kompositioner och foerfarande foer behandling av psykotiska sjukdomar
MA18628A1 (fr) Procede d'obtention de nouvelles compositions pharmaceutiques a base d'aryltrigluoroethanol
BE872843A (fr) Procede d'obtention d'aporphines
RO70855A (fr) Procede d'obtention des sulfoxydes pharmacologiquement actifs
RO73519A (fr) Procede d'obtention des corticoides
RO70887A (fr) Procede d'obtention des phenoxyalkylamides a action acaricide
PT71710B (fr) Procede pour l'obtention des nouvelles compositions pour amaigrissement
PT69475A (fr) Procede de preparation de nouvelles piperazines monosubstitiees
BE868639A (fr) Compositions chimiques a base de trihalogenures de titane, procede pour leur preparation et leur application
RO78854A (fr) Procede d'obtention des diurethanes
PT66182A (fr) Procede d'obtention de nouvelles propylenediamines
FR2422671B1 (fr) Procede pour l'obtention d'ethylsilanes
RO79322A (fr) Procede d'obtention des acides carbamiques substitus
RO79416A (fr) Procede d'obtention chloramino-s-triazines
FR2598083B1 (fr) Nouvelles compositions pharmaceutiques a action antiprogesteronique et leur procede d'obtention
FR2462423B1 (fr) Procede d'obtention de chlorothiolformiates
BE872402R (fr) Procede d'obtention du 3-bromophtalide
BE841283A (fr) Procede d'obtention de (n-beta-cyanoethylamino)-1-acylamino-3-benzenes
RO79733A (fr) Procede d'obtention d'un oligonere de difurfurylidenacetone
PT67753A (fr) Procede pour la preparation d'un medicament
BE839865A (fr) Procede pour l'obtention d'halogenophenols
RO75305A3 (fr) Procede d'obtention des comprimes vaginals moussanprocede d'obtention des comprimes vaginals ecumeuxts